Multiple Myeloma Flashcards

1
Q

What is multiple myeloma?

A
  • cancer of plasma cells
  • plasma cells typically produce antibodies and pay key role in immune immune function
  • overgrowth of abnormal plasma cells –> m-protein (MONOCLONAL)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

multiple myeloma - etiology:

A
  • more men than women
  • more AA than white
  • avg age of 65
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

heavy chains are on what chromosome?

A

14 - IgG, IgA, IgM, IgD, IgE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

which heavy chain will you see most often? second most often?

A

IgG

IgA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Light chain can be?

A

lambda or kappa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MGUS vs myeloma:

A

-monoclonal gammopathy of und significance

  • precancerous condition
  • no symptoms
  • 1% chance per year to develop myeloma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

symptoms of myeloma:

A
  • bone pain/fractures (lytic)
  • numbness/tingling in lower back/legs
  • weight loss
  • weakness (anemia), N/V, altered mental status (Could be hypercalcemia)
  • short of breath
  • urinary issues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

criteria to diagnose multiple myeloma

A

1) presence of a serum or urinary monoclonal protein (some combo of heavy and light chain)
2) presence of clonal plasma cells in the bone marrow or a plasmacytoma
3) presence of end organ damage felt related to the plasma cell dyscrasia (such as increases Ca, lytic bone lesions, anemia, or renal failure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

criteria to diagnose smoldering (asymptomatic) mutliple myeloma:

A

1) serum monoclonal proteins >=3g/dL and or >=10% to <60% of bone marrow clonal plasma cells
2) no end organ damage related to plasma cell dyscrasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

criteria to diagnose MGUS:

A

1) serum monoclonal protein <10%

3) no end organ damage related to plasma cell dyscrasia or a related b-cell lymphoprotliferative disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

INternational staging system:

A

stage 1: Beta2M=3.5
stage 2: neither stage 1 or 3
stage 3: B2M>=5.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

best survival with which stage multiple myeloma?

A

stage 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

your genetics relating to the disease determine your?

A

risk –> determines your treatment

depends mostly on chromosmoe 14 being involved (heavy chain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

treatment is based on?

A

RISK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

high risk patient,w hat is important part with treatment?

A

at least 4 months of tx and then think transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

most remission seen with what kind of transplant?

A

autologous!

17
Q

Do you continue with maintenance therapy

high risk?

A
  • YES with high risk
18
Q

plasmacytoma what is it?

A

focused area of plasma cells in the bone or other area (extramedullary)

19
Q

most likely area for a plasmacytoma?

A

humerous most
femus
pelvis
vertebra least

20
Q

criteria for plasmacytoma

A
  • all patients will have either no or low levels of M-protein in serum or urine
  • serum Ig levels are usually preserved
  • serum free light chains may be elevated
21
Q

extramedullary sites for plasmacytoma?

most common site?

A
-URT - MOST COMMON
GI,
CNS
bladder
thyroid
breasts
testes
parathyroid
LN
22
Q

extramedullary plasmacytomas

-location is…? good thing about this?

A

more localized and more curable with localized radiotherapy and/or can be removed

23
Q

Diagnosis-plasmacytoma

A
  • **-serum or urine M protein can be present in low level
  • biopsy proven solitary lesion of bone or soft tissue with evidence of clonal plasma cells
  • normal skeletal survey and MRI of spine and pelvis
  • absence of end organ damage that can be attributed to a plasa cell disorder
  • bone marrow with no evidence of plasma cells

-SHOULD NOT HAVE END ORGAN DAMAGE

24
Q

plasmacytoma treatment:

A
  • radiation therapy for bone or ST

- extramedullary plasmacytomas can be surgically removed

25
Q

Plasmacytomas BONE - outcomes:

best chance of survival and/or cure is when?

A
  • best chance is when M-protein disapears and no evidence of active disease
  • majority of patients progress to myeloma within 2 years
  • 20% disease free at 10 years
26
Q

plasmacytomas EXTRAMEDULLARY- outcomes

A

-approx 70% of patients will be alive and disease free at 10 years

27
Q

amyloidosis: what is it?

how is it different?

A
  • protein formed but it has an abnormal conformation
  • protein conformation disorder associated with clonal plasma cell dyscrasia
  • extracellular deposition of light chain fragments in an abnormal insoluble fibrillar form
  • poor correlation between impairment of organ function
28
Q

organs affected by amyloidosis:

-most common?

A
  • kidney most common - nephrotic syndrome
  • heart -restrictive cardiomyopathy
  • nerves-peripheral neuropathy
  • -liver-hepatomegaly
  • tongue-macroglossia
  • purpura (PERIORBITAL) RACCOON EYES
29
Q

*What % of myeloma patients have amyloidosis?

A

10%

30
Q

** Definite diagnosis for multiple myeloma?

A

CONGO RED STAIN - red-green birefringence under polarized light

NOT PERFECT THOUGH 50% sensitive with BM, 70% with fat pad

more sentitive with multiorgan involvement

31
Q

Amyloidosis- Poor prognostic factors?

A
  • CARDIAC (6 mo left)
  • autonomic neuropathy
  • liver involvement with hyperbilirubinemia
  • lack of suppression of underlying clonal disease by chemo
  • associated multiple myeloma
32
Q

Most important poor prognostic factor?

A

cardiac - 6 months left

33
Q

Amyloidosis treatment:

what is treatment aim?

A

no otpimal treatment - can use multiple myeloma drugs

-aim is to retard further deposition since deposition is NOT reversible

34
Q

Waldenstroms macroglobulinemia -what is the issue here?

A

-excess IgM (specific heavy change)

classified as a low grade lymphoma

-IgM in bone blood + lymphoplasmacytic lymphoma in marrow

35
Q

Waldenstroms symptoms:

A

-all related to IgM - large size getting stuck somewhere

  • neuropathy
  • Coombs postiive autoimmune hemolytic anemia
  • GI bleed
  • hyperviscosity
  • cytopenias
  • lymphadenopathy
  • hepatosplenomegaly
36
Q

waldenstroms diagnosis:

A
  • any size of IgM monoclonal gammopathy
  • bone marrow > 10% monoclonal lymphocytes and plasma cell differentiation

-combo of lymphocytes and plasma cells

37
Q

Waldenstroms treatment?

  • asymptomatic
  • symptomatic
A
  • asym = observe

- symp = chemo, plasmapheresis (if high viscosity)

38
Q

risk of progression of waldenstroms?

A

-highest in 1st 5 years

39
Q

low grade lymphomas generally are ——?

A

NOT curable - you just livewith it and treat symptoms when they bug you